Device
Laser Atherectomy
Laser Atherectomy is a medical device with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
33%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
active_not_recruiting125%
completed375%
Recent Activity
1 active trials
Showing 4 of 4
active_not_recruiting
Coronary Laser in Undilatable or Uncrossable Lesions
NCT07206082
completed
An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
NCT02921542
completed
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
NCT03306199
completednot_applicable
Laser Atherectomy Versus Angioplasty for the Treatment of Critical Limb Ischemia
NCT01579123
Clinical Trials (4)
Showing 4 of 4 trials
NCT07206082
Coronary Laser in Undilatable or Uncrossable Lesions
NCT02921542
An Evaluation of a Clinical Algorithm With Turbo-Power Following Treatment of Specific Morphologies
NCT03306199
TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions
NCT01579123Not Applicable
Laser Atherectomy Versus Angioplasty for the Treatment of Critical Limb Ischemia
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4